In vivo tissue disposition of 3'-azido-3'-deoxythymidine and its anabolites in control and retrovirus-infected mice

Drug Metabolism and Disposition

Volumn 25, Issue 4, 1997, Pages 412-422

  Chow, Hsiao Hui ^a   Li, Ping ^b   Brookshier, Gary ^b   Tang, Yang ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ZIDOVUDINE; ZIDOVUDINE 5' PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INOCULATION; ION PAIR CHROMATOGRAPHY; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RADIATION DETECTION; RETROVIRUS INFECTION; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE SPECIFICITY;

ANIMALS; FEMALE; LEUKEMIA VIRUS, MURINE; MICE; MICE, INBRED C57BL; RETROVIRIDAE INFECTIONS; TISSUE DISTRIBUTION; ZIDOVUDINE;

EID: 0030958947     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. P. A. Furman, J. A. Fyfe, M. H. S. Clair, K. Weinhold, J. L. Rideout, G. A. Freeman, S. N. Lehrman, D. P. Bolognesi, S. Broder, H. Mitsuya, and D. W. Barry: Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. U.S.A. 83, 8333-8337 (1986).
2. J. Szebeni, S. S. Patel, K. Hung, L. M. Wahl, and J. N. Weinstein: Effects of thymidine and uridine on the phosphorylation of 3′-azido-3′-deoxythymidine (zidovudine) in human mononuclear cells. Antimicrob. Agents Chemother. 35, 198-200 (1991).
3. J. Balzarini, R. Pauwels, M. Baba, P. Herdewijn, E. D. Clercq, S. Broder, and D. G. Johns: The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3′-azido-2′,3′-didexoythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell species. Biochem. Pharmacol. 37, 897-903 (1988).
4. R. K. Dhawan, S. Kharbanda, M. Nakamura, T. Ohno, and D. Kufe: Effects of granulocyte-macrophage colony-stimulating factor on 3′-azido-3′-deoxythymidine uptake, phosphorylation and nucleotide retention in human U-937 cells. Biochem. Pharmacol. 40, 2695-2700 (1990).
5. M. H. St. Clair, C. A. Richards, T. Spector, K. J. Weinhold, W. H. Miller, A. J. Langlois, and P. A. Furman: 3′-Azido-3′-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob. Agents Chemother. 31, 1972-1977 (1987).
6. R. P. Agarwal and A. M. Mian: Thymidine and zidovudine metabolism in chronically zidovudine-exposed cells in vitro. Biochem. Pharmacol. 42, 905-911 (1991).
7. J. A. Harrington, J. E. Reardon, and T. Spector: 3′-Azido-3′-deoxythymidine (AZT) monophosphate: an inhibitor of exonucleolytic repair of AZT-terminated DNA. Antimicrob. Agents Chemother. 37, 918-920 (1993).
8. B. N. Stretcher, A. J. Pesce, P. T. Frame, and D. S. Stein: Pharmacokinetics of zidovudine phosphorylation in peripheral blood mononuclear cells from patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 38, 1541-1547 (1994).
9. M. Barry, M. Wild, G. Veal, D. Back, A. Breckenridge, R. Fox, N. Beeching, F. Nye, P. Carey, and D. Timmins: Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers. AIDS 8, F1-F5 (1994).
10. G. Pantaleo, C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, S. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362, 355-358 (1993).
11. J. Embretson, M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362, 359-362 (1993).
12. R. R. Watson, R. H. Prabhala, H. R. Darban, M. D. Yahya, and T. L. Smith: Changes in lymphocyte and macrophage subset due to morphine and ethanol treatment during retroviral infection causing murine AIDS. Life Sci. 43, v-xi (1988).
13. M. B. Gardner and P. A. Luciw: Animal models of AIDS. FASEB J. 3, 2593-2606 (1989).
14. R. R. Watson: LP-BM5, a murine model of acquired immunodeficiency syndrome: role of cocaine, morphine, alcohol and carotenoids in nutritional immunomodulation. J. Nutr. 122, 744-748 (1992).
15. J. W. Hartley, T. N. Fredrickson, R. A. Yetter, M. Makino, and H. C. Morse III: Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J. Virol 63, 1223-1231 (1989).
16. L. W. Frick, D. J. Nelson, M. H. St.Clair, P. A. Furman, and T. A. Krenitsky: Effects of 3′-azido-3′-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells. Biochem. Biophys. Res. Comm. 154, 124-129 (1988).
17. E. S. J. Arner and S. Eriksson: Mammalian deoxyribonucleoside kinases. Pharmacol. Ther. 67, 155-186 (1995).
18. R. Zhang, Z. Lu, T. Liu, S. Soong, and R. Diasio: Circadian rhythm of rat spleen cytoplasmic thymidine kinase. Biochem. Pharmacol. 45, 1115-1119 (1993).
19. E. S. J. Arnér, T. Spasokoukotskaja, and S. Eriksson: Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Biochem. Biophys. Res. Comm. 188, 712-718 (1992).
20. H. Bara, T. Urano, K. Okada, K. Furukawa, E. Nakayama, H. Tanaka, K. Iwasaki, and H. Shiku: Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line. Cancer Res. 55, 1977-1981 (1995).
21. N. Shimada, N. Ishikawa, Y. Munakata, T. Toda, K. Watanabe, and N. Kimura: A second form (beta form) of nucleoside diphosphate kinase from rat. Isolation and characterization of complementary and genomic DNA and expression. J. Biol. Chem. 268, 2583-2589 (1993).
22. T. Fukuchi, N. Shimada, N. Hanai, N. Ishikawa, K. Watanbe, and N. Kimura: Recombinant rat nucleoside diphosphate kinase isoforms (a and β): purification, properties and application to immunological detection of native isoforms in rat tissues. Biochim. Biophys. Acta 1205, 113-122 (1994).
23. B. Liang, S. Ardestani, H. H. Chow, C. Eskelson, and R. R. Watson: Vitamin E deficiency and immune dysfunction in retrovirus-infected C57BL/6 mice are prevented by T-cell receptor peptide treatment. J. Nutr. 126, 1389-1397 (1996).
24. I. Stadler, K. C. Chadha, S. Nakeeb, C. Toumbis, J. Butsch, N. Mathur, F. Munschauer, A. Vladutit, S. K. Satchidanand, and J. L. Ambrus: Pentoxifylline and meclofenamic acid treatment reduces clinical manifestations in a murine model of AIDS. J. Pharmacol. Exp. Ther. 268, 10-13 (1994).
25. J. L. Eiseman, R. A. Yetter, T. N. Fredrickson, S. G. Shapiro, C. MacAuley, and J. A. Bilello: Effect of 3′-azidothymidine administered in drinking water or by continuous infusion on the development of MAIDS. Antiviral Res. 16, 307-326 (1991).
26. A. Cerny, R. Merino, L. Fossati, S. de Kossodo, C. Heusser, F. A. Waldvogel, H. C. Morse III, and S. Izui: Effect of cyclosporin A and zidovudine on immune abnormalities observed in the murine acquired immunodeficiency syndrome. J. Infect. Dis. 166, 285-290 (1992).
27. Y. Törnevik, B. Jacobsson, S. Britton, and S. Eriksson: Intracellular metabolism of 3′-azidothymidine in isolated human peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses 7, 751-759 (1991).
28. W.-Y. Gao, T. Shirasaka, D. G. Johns, S. Broder, and H. Mitsuya: Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells. J. Clin. Invest. 91, 2326-2333 (1993).
29. J. T. Slusher, S. K. Kuwahara, F. M. Hamzeh, L. D. Lewis, D. M. Kornhauser, and P. S. Lietman: Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure. Antimicrob. Agents Chemother. 36, 2473-2477 (1992).
30. E. M. Cretton, M. Xie, R. J. Bevan, N. M. Goudgaon, R. F. Schinazi, and J. P. Sommadossi: Catabolism of 3′-azido-3′-deoxythymidine in hepatocytes and liver microsomes with evidence of formation of 3′-amino3′-deoxythymidine, a highly toxic catabolite for human bone marrow cells. Mol. Pharmacol. 39, 258-266 (1992).